Glen Biotech

Alicante, Spain Founded: 2010 • Age: 16 yrs Acquired By Symborg
Biological pest control agents are developed using integrated management solutions.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Glen Biotech

Glen Biotech is a company based in Alicante (Spain) founded in 2010 was acquired by Symborg in January 2022. Glen Biotech operates in a competitive market with competitors including Oxitec, Bee Vectoring Tech, BioPhero, Beneficial Insectary and EntoCube, among others.

  • Headquarter Alicante, Spain
  • Sectors
    Agriculture
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Agriculture → Agricultural Technology & Innovation
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Symborg

    (Jan 27, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Glen Biotech

Investors in Glen Biotech

Glen Biotech has secured backing from 1 investor. Prominent investors backing the company include Symborg.

All
Investor Description Founded Year Domain Location
Development and supply of biological products for agriculture
Founded Year Domain Location

Investments & Acquisitions by Glen Biotech

Investments

Financial Statements - Glen Biotech

Glen Biotech Comparisons

+
Add Comparison
Available on Premium

Competitors of Glen Biotech

Glen Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxitec, Bee Vectoring Tech, BioPhero, Beneficial Insectary and EntoCube, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Genetically modified insects are developed to suppress pest populations.
domain founded_year HQ Location
Bee vectoring technology is developed for organic plant protection.
domain founded_year HQ Location
Insect pheromones for pest management are produced and supplied.
domain founded_year HQ Location
Beneficial insects and mites are mass-produced for agricultural pest control.
domain founded_year HQ Location
Developer of a containerized system for insect cultivation
domain founded_year HQ Location
Producer and supplier of biological pest control agents

Latest news on Glen Biotech

Frequently Asked Questions about Glen Biotech

Glen Biotech was founded in 2010.

Glen Biotech is headquartered in Alicante, Spain. It is registered at Alicante, Comunidad Valenciana, Spain.

Berenice Guerri Agullo is the current CEO of Glen Biotech.

Founded in 2010 and based in Alicante, Spain, the company operates in the biotechnology sector focused on pest control for agriculture. Integrated pest management solutions are provided, incorporating natural insecticides such as vidifol and azafit alongside biological organisms including nematodes, Bemyc fungus, and Phoemyc. These target pests like whiteflies, moths, and caterpillars in fruit trees, palm trees, and shrubs.

Glen Biotech's top competitors include Oxitec, Bee Vectoring Tech and BioPhero.

Glen Biotech has 1 investor. Key investors include Symborg.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available